Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNanoco Regulatory News (NANO)

Share Price Information for Nanoco (NANO)

Share Price is delayed by 15 minutes
Get Live Data
3.20    -0.20 (-5.88%)
Bid:
3.20
Ask:
3.44
Spread: 0.24 (7.50%)
Market Cap: £5.84m
NANO Live PriceLast checked at - London Stock Exchange

Intraday Nanoco Share Chart

Development Agreement

5 Apr 2011 07:00

RNS Number : 2895E
Nanoco Group PLC
05 April 2011
Β 

ο»Ώ

For immediate release

5 April 2011

Β 

Β 

NANOCO GROUP PLC

("Nanoco" or "the Company")

Β 

Β 

Product Development Agreement

Β 

Β 

Nanoco Group plc (AIM: NANO), a world leader in the development and manufacture of cadmium-free quantum dots, announces that, following the successful completion of its material joint development agreement (JDA) with a major Japanese electronics company, Nanoco has signed a follow-on product development agreement, triggering an upfront payment of US$800,000.

Β 

The use of quantum dots in LEDs for the backlighting of LCD TVs brings significant advantages compared with currently used technology, including superior colour performance.

Β 

Michael Edelman, Nanoco's Chief Executive Officer, said: "Having worked over the past 18 months to demonstrate that our cadmium-free quantum dots have the physical properties our partner requires, we are now very excited to be working with them to incorporate the quantum dots into a specific consumer device. This agreement marks Nanoco's progress to the final stage of taking quantum dots from the lab into a commercially available product."

Β 

Β 

For further information please contact:

Β 

Nanoco

Tel: +44 (0) 161 603 7900

Michael Edelman, Chief Executive Officer

Colin White, Chief Financial Officer

Bank of America Merrill Lynch - Corporate Broker

Tel: +44 (0) 20 7996 2490

Will Smith

Zeus Capital - Nominated Adviser

Tel: +44 (0) 161 831 1512

Alex Clarkson

Nick Cowles

Buchanan Communications

Tel: +44 (0) 20 7466 5000

Mark Court / Christian Goodbody

Β 

Β 

Notes for editors:

Β 

AboutΒ Nanoco GroupΒ plc

Nanoco is a world leader in the development and manufacture of commercial quantities of quantum dots for use in multiple applications includingΒ lighting, solar cells and biological imaging.Β Nanoco's quantum dots, which are free of heavy metals and comply with RoHS legislation, can be combined into a wide range of materials including liquids, polymers and glass.Β Nanoco forms strategic partnerships with major end users across a range of applications.

Nanoco was founded in 2001 and is based inΒ Manchester, UK. Nanoco began trading on the AIM market of the London Stock Exchange in May 2009 under the ticker symbol NANO.

For further information, please visitΒ www.nanocotechnologies.com.

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
AGRGMGGDMDKGMZZ
Date   Source Headline
21st Dec 202312:00 pmRNSAppointments of Non-Executive Directors
12th Dec 20239:35 amRNSBlocklisting six-monthly return
7th Dec 20233:23 pmRNSResult of AGM
7th Dec 20237:00 amRNSAGM Statement & Trading Update
15th Nov 20237:00 amRNSFirst ever commercial production order
13th Nov 20234:28 pmRNS2023 Annual Report and Notice of AGM
7th Nov 20237:00 amRNSJoint Development Agreement with Asian Customer
2nd Nov 20232:18 pmRNSHolding(s) in Company
17th Oct 20237:00 amRNSUnaudited Preliminary Results
10th Oct 20237:00 amRNSNotice of Results
3rd Oct 20234:32 pmRNSForeign Currency Hedge of Litigation Settlement
14th Aug 20233:58 pmRNSResult of Meeting
8th Aug 20237:00 amRNSTrading Update
7th Aug 20237:00 amRNSGlass Lewis recommends to support Nanoco’s Board
2nd Aug 20237:00 amRNSHolding(s) in Company
2nd Aug 20237:00 amRNSISS recommendation to support Nanoco’s Board
1st Aug 20237:13 amRNSTotal Voting Rights
28th Jul 20235:23 pmRNSDirector/PDMR Shareholding
25th Jul 20232:55 pmRNSPublication of Shareholder Presentation
25th Jul 202312:52 pmRNSNanoco Group Plc
24th Jul 20237:00 amRNSHigh Court Confirmation of Capital Reduction
20th Jul 20237:00 amRNSNotification of Investor Presentation
18th Jul 20237:00 amRNSPosting of Circular and Notice of General Meeting
7th Jul 202311:23 amRNSGeneral Meeting - Voting Results
28th Jun 20237:00 amRNSReceipt of General Meeting Requisition Notice
20th Jun 20237:00 amRNSPosting of Circular and Notice of General Meeting
9th Jun 20237:00 amRNSBlocklisting Six-Monthly Return
19th May 20231:00 pmRNSResponse to Shareholder Letter
21st Apr 20236:00 pmRNSHolding(s) in Company
30th Mar 202311:46 amRNSHolding(s) in Company
28th Mar 20237:00 amRNSInterim Results
27th Mar 20231:19 pmRNSResponse to Shareholder Letter
23rd Mar 20238:40 amRNSNotice of Results
9th Mar 20233:11 pmRNSHolding(s) in Company
9th Feb 20237:00 amRNSDirector/PDMR Shareholding
7th Feb 20237:00 amRNSHolding(s) in Company
3rd Feb 20237:15 amRNSTrading Update
3rd Feb 20237:15 amRNSLitigation Settlement Update
18th Jan 202311:35 amRNSHolding(s) in Company
16th Jan 202312:45 pmRNSHolding(s) in Company
11th Jan 20232:40 pmRNSHolding(s) in Company
10th Jan 20232:37 pmRNSHolding(s) in Company
9th Jan 20237:00 amRNSLitigation Settlement Update
6th Jan 20237:00 amRNSLitigation Outcome – Settlement Agreed
4th Jan 20233:31 pmRNSHolding(s) in Company
20th Dec 20223:51 pmRNSHolding(s) in Company
20th Dec 20222:59 pmRNSResult of AGM
20th Dec 20227:00 amRNSAGM Statement
13th Dec 20227:00 amRNSBlock listing Six-monthly Return
9th Dec 20227:00 amRNSLitigation Update - Firm Trial Date

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.